{"id":"activated-charcoal","safety":{"commonSideEffects":[{"rate":null,"effect":"Black discoloration of stool"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":null,"_dailymed":{"setId":"76e4fe6a-afd4-4f68-b12d-0b094f750615","title":"ACTIDOSE (ACTIVATED CHARCOAL) SUSPENSION [PADAGIS US LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Activated charcoal is a highly porous carbon material that binds various substances through physical adsorption on its large surface area. When ingested, it traps drugs, poisons, and other compounds in the GI tract, reducing systemic absorption and allowing elimination via feces. This mechanism makes it effective for acute poisoning and overdose management.","oneSentence":"Activated charcoal adsorbs toxins and drugs in the gastrointestinal tract, preventing their absorption into the bloodstream.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:05.704Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute poisoning and overdose management (multiple drugs and toxins)"},{"name":"Gastrointestinal decontamination following oral ingestion of toxic substances"}]},"trialDetails":[{"nctId":"NCT06141473","phase":"PHASE3","title":"Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-12-13","conditions":"Multiple Sclerosis","enrollment":1600},{"nctId":"NCT05471479","phase":"PHASE4","title":"Activated CHARcoal in Poisoned Patient - Pilot Trial","status":"RECRUITING","sponsor":"Laval University","startDate":"2025-07-16","conditions":"Charcoal, Decontamination, Poisoning","enrollment":100},{"nctId":"NCT07365748","phase":"NA","title":"Evaluation of Bacterial Contamination and Antimicrobial Efficacy on Charcoal-Infused vs, Standard Nylon Toothbrush Bristles.","status":"COMPLETED","sponsor":"MTI University","startDate":"2025-11-11","conditions":"to Evaluate Antimicrobial Effect of Eco-friendly Toothbrush","enrollment":36},{"nctId":"NCT07348679","phase":"NA","title":"Cigarette Filter Study","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-02-15","conditions":"Smoking ( Cigarette)","enrollment":252},{"nctId":"NCT07201311","phase":"PHASE2","title":"Combined Gastrointestinal Decontamination in Acute Severe Poisoning","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03","conditions":"Severe Poisoning With Cardiotropic or Psychotropic Drug, Admission to Intensive Care","enrollment":200},{"nctId":"NCT07301203","phase":"PHASE1","title":"Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects","status":"RECRUITING","sponsor":"Beijing Tide Pharmaceutical Co., Ltd","startDate":"2025-10-21","conditions":"Healthy, Healthy Participants","enrollment":90},{"nctId":"NCT07275684","phase":"NA","title":"Charcoal Toothbrushes and Bacterial Contamination: a Clinical Trial.","status":"COMPLETED","sponsor":"Mohammed V University in Rabat","startDate":"2025-04-16","conditions":"Oral Hygiene, Toothbrush Contamination, Bacterial Contamination","enrollment":32},{"nctId":"NCT07236996","phase":"NA","title":"Evaluation of the Health Effects of the Air Purifier in Preterm Infants After Discharge","status":"RECRUITING","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2021-05-21","conditions":"Premature - Weight 1000g-2499g or Gestation of 28-37weeks, Premature Birth","enrollment":180},{"nctId":"NCT07220031","phase":"","title":"Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay","status":"NOT_YET_RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-11-15","conditions":"Osmolality Disturbance, Lab Interference","enrollment":8},{"nctId":"NCT06376994","phase":"PHASE3","title":"Multi-Center Clean Air Randomized Controlled Trial in COPD","status":"RECRUITING","sponsor":"JHSPH Center for Clinical Trials","startDate":"2024-05-24","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":770},{"nctId":"NCT02969746","phase":"PHASE4","title":"Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants","status":"WITHDRAWN","sponsor":"University Hospital, Angers","startDate":"2014-07-18","conditions":"Anticoagulants; Circulating, Hemorrhagic Disorder","enrollment":""},{"nctId":"NCT04610294","phase":"NA","title":"Operating Room Air Filtration/Sterilization","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-05-01","conditions":"Surgery","enrollment":66273},{"nctId":"NCT04255277","phase":"PHASE1","title":"To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2020-01-31","conditions":"Healthy Subjects","enrollment":97},{"nctId":"NCT07155798","phase":"NA","title":"Evaluating Plaque Removal in Adolescents Using Bamboo and Conventional Plastic Toothbrushes","status":"RECRUITING","sponsor":"Heba Helal","startDate":"2025-09-20","conditions":"Plaque Removal","enrollment":60},{"nctId":"NCT05477108","phase":"PHASE1","title":"Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-07-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":108},{"nctId":"NCT06749067","phase":"NA","title":"Effect Of Awareness and Occupatıonal Practıces On Menopausal Women's Psychologıcal Wellbeıng And Menopausal Symptoms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kafkas University","startDate":"2024-12-01","conditions":"Mindfulness Meditation, Occupational Therapy, Psychological Well-Being","enrollment":80},{"nctId":"NCT06340581","phase":"PHASE1","title":"A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2024-10-17","conditions":"Healthy","enrollment":""},{"nctId":"NCT06906874","phase":"PHASE2","title":"Activated Charcoal Use in Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-08","conditions":"End Stage Renal Disease (ESRD), CKD 5D, Hemodialysis, CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder","enrollment":40},{"nctId":"NCT04792320","phase":"NA","title":"Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-06-19","conditions":"CKD, PAD - Peripheral Arterial Disease","enrollment":180},{"nctId":"NCT04819217","phase":"NA","title":"Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-05-01","conditions":"CKD","enrollment":180},{"nctId":"NCT04788914","phase":"NA","title":"lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-04-21","conditions":"CKD, PAD","enrollment":180},{"nctId":"NCT07047430","phase":"NA","title":"The Airports, Air Quality, and Asthma (AAA) Study","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-06-01","conditions":"Pediatric Asthma","enrollment":60},{"nctId":"NCT06925373","phase":"NA","title":"Housing, Environment, And Living Conditions for Transformed Health","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-06-18","conditions":"Lung Diseases, Chronic Disease","enrollment":460},{"nctId":"NCT05685628","phase":"NA","title":"Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-04","conditions":"Malodorous Wounds (Chronic, Malignant or Infected Wounds)","enrollment":98},{"nctId":"NCT06733636","phase":"NA","title":"Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-04-15","conditions":"Olfactory Dysfunction, Smell Loss, Anosmia","enrollment":60},{"nctId":"NCT03253653","phase":"NA","title":"Assessing Toxicity of Waterpipe Tobacco Smoking","status":"COMPLETED","sponsor":"San Diego State University","startDate":"2017-10-20","conditions":"Waterpipe Smoking","enrollment":85},{"nctId":"NCT06903429","phase":"NA","title":"Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery","status":"NOT_YET_RECRUITING","sponsor":"Kyungpook National University Chilgok Hospital","startDate":"2025-05-01","conditions":"Breast Cancer, Axillary Lymph Nodes, Target Lesion","enrollment":330},{"nctId":"NCT06800443","phase":"NA","title":"A Cosmetic Study to Measure the Change in Tooth Colour After Using Instant Whitening Prototypes Compared to a Negative Control","status":"COMPLETED","sponsor":"Unilever R&D","startDate":"2018-12-03","conditions":"Tooth Color","enrollment":68},{"nctId":"NCT05927818","phase":"NA","title":"Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer","status":"RECRUITING","sponsor":"Istanbul University","startDate":"2023-04-15","conditions":"Sentinel Lymph Node, Ovarian Carcinoma","enrollment":100},{"nctId":"NCT06163963","phase":"NA","title":"Sentinel Lymph Node in Early-Stage Endometrium Cancer","status":"RECRUITING","sponsor":"Istanbul University","startDate":"2023-07-01","conditions":"Sentinel Lymph Node, Endometrial Cancer","enrollment":100},{"nctId":"NCT06697054","phase":"NA","title":"Sentinel Lymph Node (SLN) Mapping with Charcoal Carbon Dye in Early Stage Cervical Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istanbul University","startDate":"2024-05-12","conditions":"Cervical Cancers","enrollment":60},{"nctId":"NCT06694116","phase":"NA","title":"Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istanbul University","startDate":"2024-05-30","conditions":"Vulval Cancer, Sentinel Lymph Node Detection","enrollment":40},{"nctId":"NCT06595121","phase":"PHASE1","title":"Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension)","status":"COMPLETED","sponsor":"Unither Pharmaceuticals, France","startDate":"2024-08-13","conditions":"Healthy","enrollment":24},{"nctId":"NCT05157048","phase":"NA","title":"Acute Effects of Cigarette Packaging and Charcoal Filtration on Perceptions, Use Behaviors, and Harm Exposure","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2022-03-10","conditions":"Smoking Behaviors","enrollment":42},{"nctId":"NCT05316597","phase":"NA","title":"Do Terpenes Play a Role in the Stress-reducing Effects of a Forest Bathing Intervention?","status":"COMPLETED","sponsor":"University of Washington","startDate":"2022-07-12","conditions":"Monoterpene Exposure During a Forest Bathing Intervention","enrollment":43},{"nctId":"NCT06579066","phase":"PHASE2","title":"The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-09","conditions":"Chronic Kidney Disease, Uremic Pruritus","enrollment":123},{"nctId":"NCT06441435","phase":"NA","title":"The Effect of AC-134 in Chronic Kidney Diseases","status":"NOT_YET_RECRUITING","sponsor":"Taichung Veterans General Hospital","startDate":"2024-05-24","conditions":"Nephrology","enrollment":100},{"nctId":"NCT06219967","phase":"PHASE4","title":"Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting Efficacy","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2023-01-04","conditions":"Overdose","enrollment":5},{"nctId":"NCT04465539","phase":"NA","title":"The Potential Therapeutic Role of Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-07-15","conditions":"Potential Therapeutic Role","enrollment":60},{"nctId":"NCT05498025","phase":"NA","title":"The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery","status":"COMPLETED","sponsor":"Geisinger Clinic","startDate":"2023-02-21","conditions":"Pain, Acute, Opioid Misuse, Obstetric Pain","enrollment":37},{"nctId":"NCT06171984","phase":"","title":"Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2022-07-19","conditions":"Thrombophilia","enrollment":200},{"nctId":"NCT04204772","phase":"EARLY_PHASE1","title":"A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2020-01-22","conditions":"Healthy Adult Volunteers","enrollment":12},{"nctId":"NCT04013256","phase":"NA","title":"Controlled Exposure of Healthy Nonsmokers to Secondhand and Thirdhand Cigarette Smoke","status":"SUSPENDED","sponsor":"University of California, San Francisco","startDate":"2020-01-20","conditions":"Pollution; Exposure, Smoke Inhalation, Exposure to Pollution","enrollment":66},{"nctId":"NCT03690427","phase":"NA","title":"The Cardiovascular Effects of Electronic Hookah Vaping","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2018-12-11","conditions":"Endothelial Dysfunction, Inflammation, Oxidative Stress","enrollment":19},{"nctId":"NCT05804890","phase":"","title":"Comparing Activated Carbon Cloth Dressing and Silver-Based Dressing in a Diabetic Foot Ulcer Population","status":"UNKNOWN","sponsor":"National University of Malaysia","startDate":"2022-08-01","conditions":"Diabetic Foot Ulcer","enrollment":40},{"nctId":"NCT04542473","phase":"PHASE2, PHASE3","title":"Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2021-07-01","conditions":"SEPSIS, MALNUTRITION, CHILD","enrollment":400},{"nctId":"NCT05634083","phase":"NA","title":"Does Indoxyl Sulfate Have a Role in Uremic Pruritus?","status":"COMPLETED","sponsor":"Benha University","startDate":"2022-11-25","conditions":"Pruritus","enrollment":45},{"nctId":"NCT05650840","phase":"NA","title":"Enamel Abrasion and Stain Removal Efficacy of Two Whitening Toothpastes: An In-vitro and In-vivo Trial","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-01-01","conditions":"Tooth Abrasion","enrollment":38},{"nctId":"NCT04767776","phase":"PHASE1","title":"Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2022-01-03","conditions":"Healthy","enrollment":12},{"nctId":"NCT05632094","phase":"PHASE2","title":"The Efficacy of L-Carnitine in the Management of Acute Clozapine Intoxication","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2023-06","conditions":"Clozapine Poisoning","enrollment":40},{"nctId":"NCT05619315","phase":"NA","title":"Enamel Abrasion and Stain Removal Efficacy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-12","conditions":"Abrasion, Discoloration, Tooth","enrollment":38},{"nctId":"NCT05320094","phase":"PHASE1","title":"A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2022-04-15","conditions":"Healthy Participants","enrollment":45},{"nctId":"NCT05540431","phase":"PHASE2, PHASE3","title":"Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease","status":"UNKNOWN","sponsor":"Waleed Khaild Rahman Kareem Al-kabi","startDate":"2022-09-25","conditions":"Uremic Toxin","enrollment":60},{"nctId":"NCT05510778","phase":"NA","title":"Effects of CharcoCaps® (Activated Charcoal) vs. Placebo on Intestinal Gas Production","status":"COMPLETED","sponsor":"University of Memphis","startDate":"2021-09-30","conditions":"Intestinal Gas","enrollment":20},{"nctId":"NCT05288075","phase":"PHASE1","title":"Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2022-02-28","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT05454930","phase":"NA","title":"Effect of Commute Traffic on Vascular Function","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-01","conditions":"Cardiovascular Diseases","enrollment":16},{"nctId":"NCT03802487","phase":"PHASE1","title":"Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-01-14","conditions":"Type 2 Diabetes Mellitus, Healthy Subjects","enrollment":6},{"nctId":"NCT03709368","phase":"NA","title":"Software Interventions for Improving Hand Washing and Sanitation in Rural Tanzania: an Impact Evaluation","status":"COMPLETED","sponsor":"Centre for Evidence-Based Practice, Belgium","startDate":"2018-04-23","conditions":"Diarrhea","enrollment":1500},{"nctId":"NCT02237508","phase":"PHASE1","title":"A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2014-09","conditions":"Asthma","enrollment":90},{"nctId":"NCT02631941","phase":"PHASE1","title":"Clinical Study to Evaluate Z7200 Pharmacokinetics Profile","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2016-01","conditions":"Asthma","enrollment":91},{"nctId":"NCT04928950","phase":"PHASE2","title":"Charcoal in Lung Cancer Patients Undergoing TEMLA","status":"WITHDRAWN","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2022-01-26","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT01176851","phase":"PHASE1","title":"Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2010-07","conditions":"Healthy","enrollment":20},{"nctId":"NCT01738087","phase":"PHASE2","title":"Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-11","conditions":"Asthmatic","enrollment":30},{"nctId":"NCT05098418","phase":"","title":"Trends of Acute Intoxication in Poison Control Centre","status":"UNKNOWN","sponsor":"MTI University","startDate":"2021-10-01","conditions":"Poison Drug, Poison;Medicinal;Wrong Drug, Poisoning","enrollment":10000},{"nctId":"NCT04850144","phase":"PHASE1","title":"Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2021-04-26","conditions":"Healthy Volunteers","enrollment":43},{"nctId":"NCT04856098","phase":"PHASE1","title":"Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2021-05-07","conditions":"Healthy Volunteers","enrollment":34},{"nctId":"NCT01609218","phase":"PHASE1","title":"A Study of LY2140023 in Healthy Participants","status":"COMPLETED","sponsor":"Denovo Biopharma LLC","startDate":"2012-06","conditions":"Healthy Volunteer Study","enrollment":27},{"nctId":"NCT03868436","phase":"PHASE4","title":"PENTHROX™ in the Canadian Emergency Department (ED)","status":"COMPLETED","sponsor":"Purdue Pharma, Canada","startDate":"2019-04-08","conditions":"Pain, Acute","enrollment":99},{"nctId":"NCT02359292","phase":"PHASE1","title":"Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2015-02","conditions":"Asthma","enrollment":50},{"nctId":"NCT02743013","phase":"PHASE1","title":"Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2016-04","conditions":"COPD","enrollment":50},{"nctId":"NCT03166787","phase":"PHASE1","title":"Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-08-15","conditions":"Smoking, Endothelial Dysfunction","enrollment":60},{"nctId":"NCT04644848","phase":"NA","title":"Ultrasonographic Axillary Localization","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2020-12-15","conditions":"Breast Neoplasm","enrollment":75},{"nctId":"NCT04618497","phase":"PHASE3","title":"A Pilot Study on the Use of Methoxyflurane (Penthrox®) for Pain Control in the Emergency Department","status":"COMPLETED","sponsor":"Hospital Authority, Hong Kong","startDate":"2020-10-28","conditions":"Acute Traumatic Pain","enrollment":40},{"nctId":"NCT03394911","phase":"PHASE3","title":"Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction","status":"UNKNOWN","sponsor":"Bubba Nicholson","startDate":"2020-12-31","conditions":"Opioid Addiction, Opioid Abuse, Continuous Use, Opioid Use","enrollment":500},{"nctId":"NCT01280175","phase":"PHASE1","title":"Foster With or Without Charcoal Block or Aerochamber Plus","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2006-12","conditions":"Healthy Volunteers","enrollment":13},{"nctId":"NCT01349257","phase":"PHASE2","title":"Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2011-05","conditions":"Asthma","enrollment":24},{"nctId":"NCT04494321","phase":"PHASE1","title":"A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2017-06-19","conditions":"Asthma, COPD","enrollment":99},{"nctId":"NCT02068534","phase":"","title":"A Qualitative and Quantitative Analysis on the Living History of Survivors From Charcoal-burning Suicide","status":"COMPLETED","sponsor":"Far Eastern Memorial Hospital","startDate":"2014-01","conditions":"Suicide","enrollment":20},{"nctId":"NCT03596112","phase":"NA","title":"The Difference in Wound Size Reduction Comparing Two Frequently Used Wound Dressings in Everyday Care","status":"COMPLETED","sponsor":"School of Health Sciences Geneva","startDate":"2018-09-01","conditions":"Wound Heal","enrollment":77},{"nctId":"NCT04460755","phase":"NA","title":"Tooth Whitening Evaluation With Cytotoxic and Genotoxic Effect of Commercial Whitening Toothpastes on Oral Mucosal Cells","status":"UNKNOWN","sponsor":"University of Zagreb","startDate":"2019-01-01","conditions":"Teeth Whitening","enrollment":210},{"nctId":"NCT04124094","phase":"PHASE1","title":"A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade","status":"COMPLETED","sponsor":"Respirent Pharmaceuticals Co Ltd.","startDate":"2019-10-01","conditions":"Bioequivalence","enrollment":36},{"nctId":"NCT03311373","phase":"PHASE1","title":"A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010","status":"COMPLETED","sponsor":"Pearl Therapeutics, Inc.","startDate":"2017-10-17","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":56},{"nctId":"NCT04412642","phase":"PHASE4","title":"Low Dose Methoxyflurane for Pain Relief During Minor Out-patient Urologic Procedures","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-05-31","conditions":"Pain, Acute","enrollment":10},{"nctId":"NCT04311645","phase":"PHASE2","title":"Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-08-01","conditions":"Chronic Kidney Disease stage3","enrollment":90},{"nctId":"NCT04038671","phase":"NA","title":"Activated Carbon Interphase Effect on Surgical Incisions vs.Two Common Wound Dressings","status":"WITHDRAWN","sponsor":"Brock Liden, DPM","startDate":"2019-01-07","conditions":"Surgical Wound, Healed","enrollment":""},{"nctId":"NCT03321903","phase":"","title":"EPR Tumor Oximetry With CE India Ink","status":"TERMINATED","sponsor":"Philip Schaner","startDate":"2017-08-30","conditions":"Neoplasms, Malignant, Breast Neoplasm, Carcinoma, Basal Cell","enrollment":3},{"nctId":"NCT03945344","phase":"PHASE1","title":"Effect of Charcoal on Gastrointestinal Absorption of Tiotropium","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2019-05-27","conditions":"Healthy Volunteer Study","enrollment":20},{"nctId":"NCT03710694","phase":"NA","title":"Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)","status":"COMPLETED","sponsor":"Da Volterra","startDate":"2018-10-31","conditions":"Clostridium Difficile Infection","enrollment":260},{"nctId":"NCT03743259","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2018-05-29","conditions":"Breast Diseases","enrollment":44},{"nctId":"NCT03894280","phase":"PHASE1","title":"A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)","status":"COMPLETED","sponsor":"Respirent Pharmaceuticals Co Ltd.","startDate":"2019-03-12","conditions":"Bioequivalence","enrollment":36},{"nctId":"NCT03953248","phase":"EARLY_PHASE1","title":"L-Carnitine as an Adjuvant Treatment in Acute Phosphide Poisoning (LC)","status":"COMPLETED","sponsor":"Heba Allah Ali Abd El-Halim Mabrouk","startDate":"2016-01","conditions":"Toxicity","enrollment":50},{"nctId":"NCT03951987","phase":"PHASE1","title":"Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of Charcoal","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2004-02","conditions":"Pharmacokinetic","enrollment":14},{"nctId":"NCT02685176","phase":"NA","title":"Head and Torso Rewarming Using a Human Model for Severe Hypothermia","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2016-09","conditions":"Hypothermia","enrollment":8},{"nctId":"NCT03461783","phase":"NA","title":"Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load","status":"COMPLETED","sponsor":"Brock Liden, DPM","startDate":"2017-06-26","conditions":"Wound Infection","enrollment":21},{"nctId":"NCT01389752","phase":"PHASE1","title":"A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-07","conditions":"Depressive Disorder, Major","enrollment":22},{"nctId":"NCT03776448","phase":"NA","title":"The Effect of 2 Grams Daily Supplementation of Sativa Nigra Oil on Blood Glucose Levels of Adults.","status":"UNKNOWN","sponsor":"Sulaiman AlRajhi Colleges","startDate":"2019-01","conditions":"Diabetes Mellitus","enrollment":30},{"nctId":"NCT02512302","phase":"PHASE1","title":"Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).","status":"COMPLETED","sponsor":"Sunovion Respiratory Development Inc.","startDate":"2015-10","conditions":"COPD","enrollment":30},{"nctId":"NCT02934607","phase":"PHASE1","title":"A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2016-11-04","conditions":"Study is Being Conducted in Healthy Volunteers","enrollment":50},{"nctId":"NCT01984086","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-10-21","conditions":"Asthma","enrollment":60},{"nctId":"NCT03442543","phase":"PHASE1","title":"Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2017-07-02","conditions":"Breast Cancer","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":147,"reaction":"OVERDOSE"},{"count":123,"reaction":"TOXICITY TO VARIOUS AGENTS"},{"count":111,"reaction":"OFF LABEL USE"},{"count":93,"reaction":"INTENTIONAL OVERDOSE"},{"count":88,"reaction":"DRUG INEFFECTIVE"},{"count":81,"reaction":"HYPOTENSION"},{"count":81,"reaction":"INTENTIONAL PRODUCT MISUSE"},{"count":76,"reaction":"DRUG ABUSE"},{"count":73,"reaction":"COMPLETED SUICIDE"},{"count":73,"reaction":"CONDITION AGGRAVATED"}],"_approvalHistory":[],"publicationCount":3854,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Charcoal","Medical grade AC, \"Activated Charcoal Powder, USP\", activated carbon","AC","Charclone®"],"phase":"marketed","status":"active","brandName":"Activated Charcoal","genericName":"Activated Charcoal","companyName":"State University of New York - Upstate Medical University","companyId":"state-university-of-new-york-upstate-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Activated charcoal adsorbs toxins and drugs in the gastrointestinal tract, preventing their absorption into the bloodstream. Used for Acute poisoning and overdose management (multiple drugs and toxins), Gastrointestinal decontamination following oral ingestion of toxic substances.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}